Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Accumulated Expenses: 2013-2015

Historic Accumulated Expenses for Tvardi Therapeutics (TVRD) over the last 2 years, with Dec 2015 value amounting to $1.2 million.

  • Tvardi Therapeutics' Accumulated Expenses rose 138.89% to $1.2 million in Q4 2015 from the same period last year, while for Dec 2015 it was $1.2 million, marking a year-over-year increase of 138.89%. This contributed to the annual value of $1.2 million for FY2015, which is 138.89% up from last year.
  • Per Tvardi Therapeutics' latest filing, its Accumulated Expenses stood at $1.2 million for Q4 2015, which was up 70.06% from $708,000 recorded in Q3 2015.
  • Tvardi Therapeutics' Accumulated Expenses' 5-year high stood at $1.2 million during Q4 2015, with a 5-year trough of $83,000 in Q4 2013.
  • Moreover, its 3-year median value for Accumulated Expenses was $488,000 (2014), whereas its average is $469,222.
  • Data for Tvardi Therapeutics' Accumulated Expenses shows a peak YoY soared of 507.23% (in 2014) over the last 5 years.
  • Over the past 3 years, Tvardi Therapeutics' Accumulated Expenses (Quarterly) stood at $83,000 in 2013, then spiked by 507.23% to $504,000 in 2014, then skyrocketed by 138.89% to $1.2 million in 2015.
  • Its Accumulated Expenses stands at $1.2 million for Q4 2015, versus $708,000 for Q3 2015 and $543,000 for Q2 2015.